Skip to main content
IQSM logo
IQSM
(NYSEARCA)
NYLI Candriam U.S. Mid Cap Equity ETF
$35.03-- (--)
Loading... - Market loading

IQSM ETF: NYLI Candriam U.S. Mid Cap Equity ETF - Price, Holdings & Analysis

NYLI Candriam U.S. Mid Cap Equity ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$34.47 - $35.30
52-Week High$37.14
52-Week Low$26.78
Open$34.49
Volume1.25K
Average Volume (3M)1.25K
Assets (AUM)270.78M
Expense Ratio0.15%
Total Holdings243
Inception DateOct 24, 2022
1 Day Change0.82%
1 Month Change-5.37%
6 Month Change2.55%
YTD Change0.07%
1 Year Change12.39%
52-Week Change14.08%
50-Day MA$35.82
200-Day MA$34.36
RSI49.32
Stochastic %K100.00
Stochastic %D55.11
Annual Dividend$0.41
Dividend Yield1.17%
Last Dividend Ex-DateJun 26, 2026
Dividend Growth YoY6.53%

Frequently Asked Questions About NYLI Candriam U.S. Mid Cap Equity ETF

What is the current price of IQSM?

The latest IQSM price is $35.03. The 52-week range is $26.78–$37.14. IQSM has returned 14.1% over the past 52 weeks.

What is the expense ratio for IQSM?

IQSM's annual expense ratio is 0.15%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does IQSM pay dividends?

Yes, IQSM pays a 1.17% dividend yield. The last ex-dividend date was 2026-06-26. View full dividend history in the Dividends section.

What are the top holdings of IQSM?

IQSM's largest holdings are TechnipFMC plc (1.3%), Lumentum Holdings Inc (1.1%), United Therapeutics Corporation (1.1%) (combined weight: 3.5%). The fund holds 243 total positions. View the complete portfolio breakdown in the Holdings section.

How does IQSM compare to similar ETFs?

Compare IQSM (0.15% expense ratio, $271M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.